학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 57건 | 목록 1~10
Academic Journal
Fernández-García F; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Fernández-Rodríguez A; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Fustero-Torre C; Bioinformatics Unit, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Piñeiro-Yáñez E; Bioinformatics Unit, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Wang H; School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.; Lechuga CG; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Callejas S; Genomic Unit, Centro Nacional de Investigaciones Cardiovasculares, Madrid 28029, Spain.; Álvarez R; Genomic Unit, Centro Nacional de Investigaciones Cardiovasculares, Madrid 28029, Spain.; López-García A; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Esteban-Burgos L; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Salmón M; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; San Román M; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Guerra C; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid 28029, Spain.; Ambrogio C; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino 10126, Italy.; Drosten M; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid 28029, Spain.; Molecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas-Universidad de Salamanca, Salamanca 37007, Spain.; Santamaría D; Molecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas-Universidad de Salamanca, Salamanca 37007, Spain.; Al-Shahrour F; Bioinformatics Unit, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Dopazo A; Genomic Unit, Centro Nacional de Investigaciones Cardiovasculares, Madrid 28029, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid 28029, Spain.; Barbacid M; Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid 28029, Spain.; Musteanu M; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid 28029, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Madrid 28040, Spain.; Cancer and Obesity Group, Health Research Institute of San Carlos, Madrid 28040, Spain.
Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Academic Journal
Salmón M; Experimental Oncology Group, Molecular Oncology Program.; Álvarez-Díaz R; Experimental Oncology Group, Molecular Oncology Program.; Fustero-Torre C; Bioinformatics Unit.; Brehey O; Experimental Oncology Group, Molecular Oncology Program.; Lechuga CG; Experimental Oncology Group, Molecular Oncology Program.; Sanclemente M; Experimental Oncology Group, Molecular Oncology Program.; Fernández-García F; Experimental Oncology Group, Molecular Oncology Program.; López-García A; Experimental Oncology Group, Molecular Oncology Program.; Martín-Guijarro MC; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program.; Rodríguez-Perales S; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program.; Bousquet-Mur E; Experimental Oncology Group, Molecular Oncology Program.; Morales-Cacho L; Experimental Oncology Group, Molecular Oncology Program.; Mulero F; Molecular Imaging Unit.; Al-Shahrour F; Bioinformatics Unit.; Martínez L; Flow Cytometry Unit.; Domínguez O; Genomics Unit.; Caleiras E; Histopathology Unit, and.; Ortega S; Mouse Genome Editing Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Guerra C; Experimental Oncology Group, Molecular Oncology Program.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Musteanu M; Experimental Oncology Group, Molecular Oncology Program.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University, Madrid, Spain.; Drosten M; Experimental Oncology Group, Molecular Oncology Program.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Molecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer (CIC) and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas-Universidad de Salamanca (CSIC-USAL), Salamanca, Spain.; Barbacid M; Experimental Oncology Group, Molecular Oncology Program.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Academic Journal
Calsina B; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. bcalsina@cnio.es.; Piñeiro-Yáñez E; Bioinformatics Unit, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Martínez-Montes ÁM; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Caleiras E; Histopathology Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Fernández-Sanromán Á; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Monteagudo M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Torres-Pérez R; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Bioinformatics for Genomics and Proteomics, National Centre for Biotechnology (CNB-CSIC), Madrid, Spain.; Fustero-Torre C; Bioinformatics Unit, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Pulgarín-Alfaro M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Gil E; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Letón R; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Jiménez S; Monoclonal Antibodies Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; García-Martín S; Bioinformatics Unit, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Martin MC; Molecular Cytogenetics and Genome Engineering Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Roldán-Romero JM; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Lanillos J; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Mellid S; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Santos M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Díaz-Talavera A; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.; Rubio Á; Genomics Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; González P; Histopathology Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Hernando B; Computational Oncology Group, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Bechmann N; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Dona M; Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.; Calatayud M; Department of Endocrinology, 12 de Octubre University Hospital, Madrid, Spain.; Guadalix S; Department of Endocrinology, 12 de Octubre University Hospital, Madrid, Spain.; Álvarez-Escolá C; Department of Endocrinology, La Paz University Hospital, Madrid, Spain.; Regojo RM; Department of Pathology, La Paz University Hospital, Madrid, Spain.; Aller J; Department of Endocrinology, Puerta de Hierro University Hospital, Madrid, Spain.; Del Olmo-Garcia MI; Department of Endocrinology and Nutrition, University Hospital La Fe, Valencia, Spain.; López-Fernández A; Department of Medical Oncology, Vall d'Hebrón Hospital, Barcelona, Spain.; Fliedner SMJ; Neuroendocrine Oncology and Metabolism, Medical Department I, Center of Brain, Behavior, and Metabolism, University Medical Center Schleswig-Holstein Lübeck, Lübeck, Germany.; Rapizzi E; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.; Fassnacht M; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, University of Würzburg, Würzburg, Germany.; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.; Beuschlein F; Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.; Klinik für Endokrinologie Diabetologie und Klinische Ernährung, Universitätsspital Zürich (USZ) und Universität Zürich (UZH), Zürich, Switzerland.; Quinkler M; Endocrinology in Charlottenburg Stuttgarter Platz 1, Berlin, Germany.; Toledo RA; Gastrointestinal and Endocrine Tumors, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Institute of Health Carlos III (ISCIII), Madrid, Spain.; Mannelli M; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.; Timmers HJ; Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.; Eisenhofer G; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Rodríguez-Perales S; Molecular Cytogenetics and Genome Engineering Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Domínguez O; Genomics Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Macintyre G; Computational Oncology Group, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Currás-Freixes M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Department of Endocrinology, Clínica Universidad de Navarra, Madrid, Spain.; Rodríguez-Antona C; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.; Cascón A; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.; Leandro-García LJ; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Montero-Conde C; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.; Roncador G; Monoclonal Antibodies Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; García-García JF; Department of Pathology, MD Anderson Cancer Center, Madrid, Spain.; Pacak K; Section of Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.; Al-Shahrour F; Bioinformatics Unit, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Robledo M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. mrobledo@cnio.es.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain. mrobledo@cnio.es.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] C. Fustero-Torre
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어